Roche Proposes Nominees for Ventana's Board of Directors | GenomeWeb
NEW YORK (GenomeWeb News) - In another strategic move in its attempt to acquire Ventana Medical Systems, Roche plans to nominate four independent candidates for Ventana’s board of directors, Roche said in a statement yesterday.
 
Roche also hopes to change Ventana’s bylaws to remove its classified board and reduce its number of directors from 10 to seven.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.